Cash & equivalents decreased 32.0%
Cash & equivalents changed -32.0% from the comparable as-filed period.
$95.0M→$64.6M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →CVRX financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Gross margin moved 313 bp higher
Gross margin changed +313 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
84.26%→87.39%4 prior comparisons
Inventory increased 11.2%
Inventory changed +11.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$11.7M→$13.0M4 prior comparisons
Operating margin moved 2287 bp higher
Operating margin changed +2287 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
-105.79%→-82.92%4 prior comparisons
Research & development increased 26.8%
Research & development changed +26.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$2.5M→$3.1M4 prior comparisons
Stock-based compensation increased 25.6%
Stock-based compensation changed +25.6% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$2.9M→$3.7M4 prior comparisons
Gross profit increased 19.9%
Gross profit changed +19.9% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$11.5M→$13.7M4 prior comparisons
Revenue increased 15.6%
Revenue changed +15.6% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$13.6M→$15.7M4 prior comparisons
Operating income increased 9.4%
Operating income changed +9.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
-$14.4M→-$13.0M4 prior comparisons
Net income increased 4.7%
Net income changed +4.7% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
-$14.7M→-$14.0M4 prior comparisons
Selling, general & administrative increased 1.1%
Selling, general & administrative changed +1.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$23.4M→$23.6M4 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.